Assessment of Immune Response in Multiple Sclerosis Patients With COVID-19/Vaccination Treated With Ofatumumab and Other Disease Modifying Therapies
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Asciminib RMP Study
- Status
- RECRUITING
- Phase
- N/A
CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
- Status
- RECRUITING
- Phase
- PHASE3
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL): Inpatient and Outpatient Settings
- Status
- COMPLETED
- Phase
- N/A
An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
- Status
- COMPLETED
- Phase
- N/A
A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Retrospective Assessment of AE-Related Healthcare Resource Utilization and Costs of Immune Checkpoint Inhibitor and Targeted Therapy for Adjuvant Treatment of Melanoma
- Status
- COMPLETED
- Phase
- N/A
CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients With Chronic Heart Failure
- Status
- WITHDRAWN
- Phase
- N/A
Adherence and Persistence to Inclisiran Among Early Users in Germany
- Status
- COMPLETED
- Phase
- N/A
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- N/A
Examining the Clinical Characteristics, Treatment Patterns, Real-world Effectiveness, and Healthcare Resource Utilization of Patients With Dry Eye Disease
- Status
- WITHDRAWN
- Phase
- N/A